She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
The brief
"She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by Newsylist so far.
Outlets currently covering the story include Drug Topics, BBC Science Focus Magazine, Yahoo and ScienceDaily. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by Newsylist's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by Newsylist's extractive engine from coverage metadata only — no AI-written claims. Updated 50d ago.
Who reported it (8)
- Weight loss drug linked to more poison control calls, UT San Antonio researchers say Spectrum News · 51d ago
- GLP-1 Overdose Sends 54-Year-Old Woman to Hospital The Daily Beast · 51d ago
- Woman Hospitalized, Vomiting Every 20 Minutes After GLP-1 Overdose: ‘I Wouldn’t Put That On My Worst Enemy’ People.com · 51d ago
- Data Show Rise in GLP-1 Poison Center Calls Tied to Dosing Errors Drug Topics · 51d ago
- 61 surprising ways weight-loss drugs can change your body BBC Science Focus Magazine · 51d ago
- Inside Look at Concerns Around Weight Loss Drug Overdoses Yahoo · 51d ago
- The Ozempic and Wegovy mistake sending thousands to poison control ScienceDaily · 51d ago
- She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER TODAY.com · 51d ago broke it first
Quick answers
Why is "She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst Newsylist classifies as a trend.
How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
Researchers find new benefits, risks in GLP-1 weight loss drugs
Scientists uncover unexpected benefits and new risks surrounding widely used GLP-1 weight loss medications.
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
Compounded GLP-1 drugs creating concern among doctors and FDA
Compounded GLP-1 weight‑loss drugs face mounting scrutiny as doctors and regulators flag safety concerns.
Weight-loss jab users warned about relationship side effect no one prepares you for
GLP‑1 weight‑loss drugs are reshaping women’s marriage prospects and job markets, while sparking warnings about unseen relationship strain.
Scientists Searching 6,000 Drugs For Anti-Aging Properties Found One Hiding in Plain Sight
Researchers identify existing medications, including GLP-1 drugs and nasal sprays, as potential candidates for slowing biological aging processes.
Three Takeaways From Andoni Iraola’s Victorious Debut As Liverpool Manager
Andoni Iraola secures a winning start to his tenure as Liverpool manager during an exhibition match in Nashville.